Green Cross (KO:005250) — Market Cap & Net Worth
Market Cap & Net Worth: Green Cross (005250)
Green Cross (KO:005250) has a market capitalization of $342.58 Million (₩505.51 Billion) as of June 19, 2026. Listed on the KO stock exchange, this Korea-based company holds position #14302 globally and #458 in its home market, demonstrating a 10.51% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Green Cross's stock price ₩11250.00 by its total outstanding shares 44934190 (44.93 Million). Review Green Cross (005250) financial obligations to assess the company's total debt and financial obligations.
Green Cross Market Cap History: 2015 to 2026
Green Cross's market capitalization history from 2015 to 2026. Data shows change from $1.16 Billion to $342.58 Million (-9.85% CAGR).
Green Cross Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Green Cross's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Green Cross's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.02x
Green Cross's market cap is 0.02 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.16 Billion | $1.13 Trillion | $65.42 Billion | 0.00x | 0.02x |
| 2016 | $665.44 Million | $1.35 Trillion | $47.18 Billion | 0.00x | 0.01x |
| 2017 | $1.11 Billion | $1.46 Trillion | $43.36 Billion | 0.00x | 0.03x |
| 2018 | $714.54 Million | $1.55 Trillion | $18.47 Billion | 0.00x | 0.04x |
| 2019 | $642.80 Million | $1.52 Trillion | $2.96 Billion | 0.00x | 0.22x |
| 2020 | $1.22 Billion | $1.72 Trillion | $170.96 Billion | 0.00x | 0.01x |
| 2021 | $808.12 Million | $1.84 Trillion | $55.27 Billion | 0.00x | 0.01x |
| 2022 | $517.67 Million | $2.08 Trillion | $32.82 Billion | 0.00x | 0.02x |
| 2023 | $497.88 Million | $2.06 Trillion | -$54.14 Billion | 0.00x | N/A |
| 2024 | $527.42 Million | $2.20 Trillion | $24.03 Billion | 0.00x | 0.02x |
Competitor Companies of 005250 by Market Capitalization
Companies near Green Cross in the global market cap rankings as of June 19, 2026.
Key companies related to Green Cross by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #221 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #445 globally with a market cap of $62.84 Billion USD.
- UCB SA (BR:UCB): Ranked #547 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #221 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $451.63 |
| #445 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.84 Billion | $609.94 |
| #547 | UCB SA | BR:UCB | $49.68 Billion | €249.20 |
| #573 | Argen-X | BR:ARGX | $47.14 Billion | €762.80 |
Green Cross Historical Marketcap From 2015 to 2026
Between 2015 and today, Green Cross's market cap moved from $1.16 Billion to $ 342.58 Million, with a yearly change of -9.85%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩342.58 Million | -29.33% |
| 2025 | ₩484.78 Million | -8.08% |
| 2024 | ₩527.42 Million | +5.93% |
| 2023 | ₩497.88 Million | -3.82% |
| 2022 | ₩517.67 Million | -35.94% |
| 2021 | ₩808.12 Million | -33.61% |
| 2020 | ₩1.22 Billion | +89.37% |
| 2019 | ₩642.80 Million | -10.04% |
| 2018 | ₩714.54 Million | -35.40% |
| 2017 | ₩1.11 Billion | +66.22% |
| 2016 | ₩665.44 Million | -42.53% |
| 2015 | ₩1.16 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Green Cross was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $342.58 Million USD |
| MoneyControl | $342.58 Million USD |
| MarketWatch | $342.58 Million USD |
| marketcap.company | $342.58 Million USD |
| Reuters | $342.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Green Cross
Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pert… Read more